<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"ACL":1,
"ALK rearrangement":1,
"smoking history":1,
"unselected Caucasian population":1,
"Epidermal growth factor receptor":1,
"Epithelial-to-mesenchymal transition":1,
"Hepatocellular carcinoma":3,
"Hepatocellular carcinoma related protein 1":1,
"Breast cancer":8,
"DNA methylation":3,
"Methyl donors":1,
"Apoptosis":2,
"Invasion":1,
"Osteosarcoma":1,
"Proliferation":4,
"Pyruvate kinase type M2":1,
"Tumor orthotopic model":1,
"Immune-related adverse events":1,
"Interleukin-2":1,
"Melanoma":1,
"PROCLAIMSM":1,
"Renal cell carcinoma":1,
"Survival":3,
"Prox-1":1,
"cat":1,
"immunohistochemistry":3,
"lymphendothelium":1,
"plexiform vasculopathy":1,
"Elasticity imaging techniques":1,
"Shear wave":1,
"Thyroid cancer, papillary":1,
"Thyroid nodule":9,
"Autistic Disorder":1,
"Caries":1,
"Fluoride":1,
"Growth and Development":1,
"Mental Retardation":1,
"Thyroid Gland":3,
"Carcinoma de tiroides":1,
"Carcinoma folicular":1,
"Carcinoma papilar":1,
"Follicular carcinoma":1,
"Papillary carcinoma":1,
"Thyroid carcinoma":7,
"Thyroidectomy":5,
"Tiroidectomía":1,
"Robotic":1,
"cervical lymphadenectomy":1,
"neck dissection":1,
"papillary thyroid carcinoma":19,
"squamous cell carcinoma":2,
"Diagnosis":4,
"Malignancy risk":1,
"Molecular marker":1,
"Thyroid nodules":3,
"Ultrasound":2,
"Lateral lymph node metastasis":1,
"Papillary thyroid microcarcinoma":3,
"Predictors":1,
"Skip metastasis":1,
"glycogen":1,
"long noncoding RNA":1,
"migration":1,
"synthase kinase 3β":1,
"Breast neoplasms":2,
"Care delay":1,
"Patient delay":1,
"Prognosis":7,
"Related factors":1,
"NIS":2,
"differentiation":1,
"drug resistance":1,
"targeted therapy":2,
"Afirma":1,
"TIRADS":1,
"endocrine surgery":1,
"indeterminate nodules":2,
"interobserver variability":1,
"thyroid":9,
"CTLA4":1,
"Cancer treatment":1,
"Endocrine side effects":1,
"Hyponatremia":1,
"Hypophysitis":1,
"Immune checkpoint inhibitors":1,
"PD1/PD1-L":1,
"Thyroid diseases":1,
"SphK2":1,
"lncRNA LINC00460":1,
"miR-613":1,
"elastosonography":1,
"shear wave elastography":3,
"thyroid cancer":25,
"Apocrine papillary lesion":1,
"Encapsulated apocrine papillary carcinoma":1,
"Papilloma with DCIS":1,
"cholecystokinin-2 receptor":1,
"minigastrin":1,
"molecular imaging":1,
"radiometals":1,
"targeted radiotherapy":1,
"Thyroid papillary microcarcinoma":1,
"thyroid lobo-isthmectomy":1,
"total thyroidectomy":3,
"Carcinoma":3,
"Clinicopathology":1,
"Hashimoto thyreoiditis":1,
"Molecular pathology":1,
"Adipofascial flap":1,
"Oncoplastic breast surgery":1,
"Slim body":1,
"Volume replacement":1,
"Cytology":2,
"Location":1,
"Neoplasms":2,
"Thyroid Imaging, Reporting, and Data System":1,
"2-stage":1,
"posterior tibial artery perforator flap":1,
"tracheal invasion":1,
"tracheal reconstruction":1,
"LY294002":1,
"Lamc1":1,
"PKM2":1,
"PTEN/AKT pathway":1,
"si-p110 PI3K":1,
"TSH":1,
"glucose":1,
"papillary thyroid cancer":9,
"thyroid hormone":1,
"thyroid-stimulating hormone":1,
"anterior chest approach":1,
"endoscopic thyroidectomy":1,
"lateral neck dissection":1,
"needle assisted":1,
"Ablation techniques":1,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Nodular goiter":1,
"Ultrasound imaging":1,
"anaplastic":2,
"cancer":4,
"cancer trial":1,
"chemotherapy":2,
"clinical trial":1,
"clinicaltrials gov":1,
"follicular":1,
"head and neck cancer":1,
"medullary":1,
"papillary":1,
"pubmed gov":1,
"radiation therapy":1,
"radioactive iodine":1,
"surgery":2,
"thyroid malignancy":1,
"cost effectiveness":1,
"differentiated thyroid cancer":5,
"extent of surgery":1,
"healthcare cost":1,
"Bethesda system":1,
"fine-needle aspiration biopsy":1,
"prevalence":2,
"test characteristics":1,
"calcitonin reference range":1,
"electrochemiluminescence immunoassay":1,
"medullary thyroid cancer":2,
"multiple endocrine neoplasia type 2":1,
"AUS/FLUS":1,
"LncRNA":1,
"PTC":3,
"UNC5B-AS1":1,
"Evaluation":1,
"Immunoassay":1,
"Isotope-diluted liquid chromatography tandem mass spectrometry":1,
"Performance":1,
"Thyroxine":1,
"Ultrasound diagnosis":1,
"epithelial-mesenchymal transition":2,
"junctional adhesion molecule A":1,
"motility":1,
"differentiated thyroid carcinoma":3,
"minirecovery":1,
"thyroglobulin":1,
"thyroglobulin antibodies":1,
"body mass index":1,
"extrathyroidal invasion":1,
"locoregional recurrence":1,
"vascular invasion":1,
"HK2":1,
"miR-143":1,
"microPET/CT":1,
"poorly differentiated thyroid carcinoma":1,
"visual evaluation":1,
"lymph nodes":1,
"lymphatic metastasis":1,
"meta-analysis":4,
"thyroid neoplasms":3,
"Atherosclerosis":1,
"Inflammation":1,
"Positron emission tomography (PET)":1,
"TSH suppression":2,
"Thyroid disease":3,
"B-mode grayscale ultrasound":1,
"fine-needle aspiration cytology":1,
"thyroid nodule size":1,
"131-radioiodine therapy":1,
"Levo-thyroxine withdrawal":1,
"Radioiodine side effects":1,
"rhTSH stimulation":1,
"circulating microRNAs":1,
"miR-146":1,
"miR-221":1,
"miR-222":1,
"microRNAs":1,
"prognostic":1,
"Benign nodules":2,
"Clinical effect":1,
"Microwave ablation":1,
"Stress response":1,
"Magnetic tracer":1,
"Sentinel lymph node biopsy":1,
"Superparamagnetic iron oxide (SPIO)":1,
"Completion thyroidectomy":2,
"Complications":1,
"Hypocalcaemia":1,
"Oncological benefits":1,
"131I":1,
"1ng/mL":1,
"Pre-ablation stimulated thyroglobulin":1,
"AGK-BRAF":1,
"BRAF V600E":2,
"pediatric thyroid cancer":1,
"RET":3,
"Ser891Ala":1,
"founder effect":1,
"prophylactic thyroidectomy":1,
"Bethesda system for reporting thyroid cytopathology-BSRTC":1,
"Fine needle aspiration-FNA":1,
"Follicular neoplasm with papillary like nuclear features-NIFTP":1,
"Risk of malignancy-ROM":1,
"Early detection":1,
"GC/MS":1,
"LC/MS":1,
"Metabolomics":1,
"NMR":1,
"Thyroid cancer diagnosis":1,
"CD47":1,
"anaplastic thyroid carcinoma":2,
"immune checkpoints":1,
"phagocytosis":1,
"programmed cell death 1":1,
"tumor-associated macrophages":1,
"fine-needle aspiration":2,
"occult lateral neck lymph node metastasis":1,
"pathological features":1,
"High risk":1,
"Radioiodine ablation":1,
"Retrospective study":1,
"candidate genes":1,
"familial non-medullary thyroid carcinoma":1,
"germline predisposition variants":1,
"rare variants":1,
"whole-genome sequencing":1,
"Differentially expressed genes (DEGs)":1,
"Papillary thyroid carcinoma (PTC)":3,
"Pathological stage":1,
"Weighted gene co-expression network analysis (WGCNA)":1,
"Colorectal cancer":1,
"Gastric cancer":1,
"Lipidomics":1,
"Liver cancer":1,
"Lung cancer":4,
"Plasma":1,
"UHPLC-ESI-MS/MS":1,
"hyperparathyroidism":1,
"lncRNAs":1,
"parathyroid tumors":1,
"Variance-Reduction statistic":1,
"automatic detection":1,
"nodule boundary":1,
"ultrasound images":1,
"RNA interference":1,
"Wnt/β-catenin signaling":1,
"breast carcinoma":1,
"minichromosome maintenance protein 10":1,
"Cancer vaccines":1,
"Carbohydrate":1,
"Immunotherapy":1,
"Tumor-associated carbohydrate antigens":1,
"elasticity":1,
"ultrasonography":1,
"Dihydroartemisinin":1,
"Esophageal cancer":1,
"Glycolysis":1,
"Pyruvate kinase M2":1,
"Efficacy":1,
"Sorafenib":2,
"Thyroid neoplasm":2,
"Tumor doubling time":1,
"epidemiology":1,
"incidence":2,
"pediatrics":2,
"registries":1,
"Medullary carcinoma":1,
"Radiotherapy":1,
"Systematic review":1,
"disability":1,
"neck pain":1,
"trigger points":1,
"I treatment":1,
"bone metastases":1,
"multimodal treatment":1,
"overall survival":1,
"prognostic factors":1,
"BRAFV600E mutation":1,
"Sanger sequencing":1,
"ddPCR":1,
"extranodal extension":1,
"recurrence":4,
"risk-stratification system":1,
"BRAF":1,
"RAS":1,
"TERT":1,
"mutation":1,
"radioactive iodine refractory (RAIR)":1,
"hyperthyroidism":1,
"thyrotoxicosis":1,
"biomarkers":1,
"demethylating drugs":1,
"global hypomethylation":1,
"Cancer staging":1,
"Vitamin D":2,
"active surveillance":1,
"quality of life":1,
"circular RNA":3,
"malignant cancer":1,
"receiver operating characteristic":1,
"serum biomarker":1,
"CDK6":1,
"LINC00511":1,
"Paclitaxel cytotoxicity":1,
"miR-29c":1,
"Graves’ disease":1,
"autoantibody":1,
"decoy effect":1,
"exosome":1,
"thyrotropin receptor":1,
"Kidney Neoplasms":1,
"Contrast-enhanced ultrasound":1,
"Gray-scale ultrasound":1,
"Thyroid Imaging Reporting and Data System":1,
"TI-RADS":1,
"medullary thyroid carcinoma (MTC)":1,
"modified":1,
"CFL1":1,
"LIMK1":1,
"Progression":1,
"miR-128-3p":1,
"Single nucleotide polymorphisms":1,
"UGT2B7":1,
"EZH2":1,
"H3K27":1,
"miR-124/506":1,
"HOXB8":1,
"MIF-AS1":1,
"ceRNA":1,
"miR-1249-3p":1,
"Akt":1,
"Evodiamine":1,
"HDAC inhibitor":1,
"Synergism":1,
"Classic type papillary thyroid microcarcinoma":1,
"Follicular variant of papillary thyroid microcarcinoma":1,
"Risk factor":2,
"Thyroid microcarcinoma smaller than 5 mm":1,
"Environmental exposure":1,
"Heavy metals":1,
"Urine":1,
"KIF5B–RET":1,
"cancer biology":1,
"cancer therapy":1,
"inhibitor":1,
"mutant":1,
"structural biology":1,
"tyrosine-protein kinase (tyrosine kinase)":1,
"METTL7B":1,
"metastasis":2,
"Biomarker":2,
"COL1A1":1,
"Extracellular matrix":1,
"Gene expression":1,
"accelerated aging":1,
"network analysis":1,
"pan-cancer":1,
"Detection":1,
"Insulin resistance":1,
"Nodules":1,
"Obesity":1,
"Endoscopy":1,
"Minimally invasive surgical procedure":1,
"TOETVA":1,
"Transoral":1,
"Transoral thyroidectomy":1,
"aggressive variants":1,
"anaplastic carcinoma":1,
"fine needle aspiration cytology":3,
"personalized medicine":1,
"poorly differentiated carcinoma":1,
"Biopsy":1,
"malignancy":2,
"positron emission tomography-computerized tomography":1,
"thyroid incidentaloma":1,
"Adenocarcinoma lung":1,
"nonthyroidal thyroid metastasis":1,
"papillary carcinoma thyroid":1,
"thyroid metastasis":1,
"Diffuse large B-cell lymphoma":1,
"MALT lymphoma":1,
"extranodal":1,
"lymphoma":1,
"marginal zone lymphoma":1,
"Health-care costs":1,
"retrospective cohort studies":1,
"Lateral lymph node":1,
"thyroid papillary carcinoma":2,
"giant cells":1,
"osteoclasts":1,
"Bilaterality":1,
"Multifocality":1,
"collimators":1,
"parallel-hole collimators":1,
"radioiodine":1,
"scintigraphy":2,
"whole-body imaging":1,
"“pin-hole”":1,
"Fine needle aspiration biopsy":1,
"Lymph node metastasis":2,
"Papillary microcarcinoma":1,
"Proteomics":1,
"genetic predisposition":1,
"genetic sequencing":1,
"polycystic kidney disease":1,
"YWHAZ":1,
"14-3-3 zeta":1,
"gastric carcinoma":1,
"miR-375":1,
"dose constraint":1,
"supraclavicular radiotherapy":1,
"thyroid gland dose":1,
"clinicopathological features":1,
"epidemiological features":1,
"basal subtype":1,
"matrix-producing carcinoma":1,
"neoadjuvant chemotherapy":1,
"triple-negative":1,
"Fistula":1,
"angiogenesis inhibitor":1,
"bleeding":1,
"lenvatinib":1,
"LINC00982":1,
"PI3K/AKT":1,
"cell proliferation":1,
"Adenomas":1,
"Endocrinology":1,
"Endoscopic endonasal surgery":1,
"Multidisciplinary team":1,
"Pituitary/hypothalamus":1,
"Radiation oncology":1,
"Targeted drugs":1,
"IGF axis":1,
"therapeutic approach":1,
"anaplastic thyroid cancer":1,
"clinical trials":1,
"precision medicine":1,
"AHP methodology":1,
"Health technology assessment":1,
"Likert scale":1,
"Multicriteria decision problems":1,
"Prophylactic central neck dissection":1,
"Boxer":1,
"Cervical mass":1,
"Thyroid cyst":1,
"Thyroid cystic adenoma":1,
"Advanced gastric cancer":1,
"Chemotherapy response":1,
"Neutrophil–lymphocyte ratio":1,
"Platelet–lymphocyte ratio":1,
"G548V":1,
"MEN 2":1,
"MTC":1,
"Medullary thyroid carcinoma":2,
"Retrocopy":1,
"Second hit":1,
"Complication rates":1,
"Computed tomography":1,
"Disease-free survival":1,
"Invasive mucinous adenocarcinoma":1,
"Case report":2,
"Histological findings":1,
"Multiple metastases":1,
"Pancreatic neuroendocrine tumors":1,
"Rare metastatic localization":1,
"Surgical treatment":1,
"ADC":1,
"DWI":1,
"MRI":1,
"Region of interest":1,
"Cancer incidence":1,
"Human cancers":1,
"Sexual dimorphism":1,
"BRAF V600E mutation":1,
"Co-mutations":1,
"NRAS mutation":1,
"TERT mutation":1,
"DEGs":1,
"KEGG pathway":1,
"PPI network":1,
"bioinformatic analysis":1,
"miRNA-gene network":1,
"MicroRNA":1,
"Plasma samples":1,
"calcium and bone":2,
"pituitary disorders":2,
"Association":1,
"Primary hyperparathyroidism":2,
"Secondary hyperparathyroidism":2,
"effect modification by BMI status":1,
"mitochondrial DNA copy number":1,
"oxidative DNA damage":1,
"two-stage case-control study":1,
"Calcitonin":3,
"Carcinoma, medullary":1,
"Cost-benefit analsis":1,
"prostate":1,
"GATAD2A":1,
"Hsa_circ_0058124":1,
"NOTCH3":1,
"Hypercalcitoninemia":1,
"Parathyroid surgery":1,
"Renal insufficiency":1,
"genetics":2,
"forearm autotransplantation":1,
"hyperparathyroidism, secondary":1,
"parathyroidectomy":1,
"lateral neck transfer":1,
"parapharyngeal transfer":1,
"AMPK":1,
"Autophagy":1,
"HMGB1":1,
"mTOR":1,
"ACE27":1,
"ASA":1,
"advanced age":1,
"elderly":1,
"free flaps":1,
"medical complications":1,
"oral cancer":1,
"surgical complications":1,
"Bladder cancer":1,
"EGFR":1,
"TRIP13":1,
"Tumorigenesis":1,
"Bone and bones":1,
"Leiomyosarcoma":1,
"Liver":1,
"Spine":1,
"multiple primary":1,
"8505C cells":1,
"BCPAP cells":1,
"DU145 cells":1,
"HL-60 cells":1,
"LNCaP cells":1,
"cancer gene software":1,
"kidney cancer":1,
"prostate cancer":1,
"polymorphisms":1,
"Refractory psoriasis":1,
"Sarcoid-like reaction":1,
"Sarcoidosis":1,
"Ustekinumab":1,
"Poria cocos":1,
"inhibit SATB1 expression":1,
"inhibit migration of human breast cancer MDA-MB-231 cells":1,
"polysaccharide":1,
"sulfuric acid derivatization":1,
"SFRP1":1,
"miR-509-5p":1,
"Cancer research":1,
"Canis familiaris":1,
"Oncogene protein HER-2":1,
"Oncology":1,
"Pathology":1,
"Veterinary medicine":1,
"Central nervous system":1,
"metastatic":1,
"primary":1,
"tumors":1,
"Milan classification":1,
"histopathology":2,
"salivary glands":1,
"Auto-immune disease":1,
"Oral lichen planus":1,
"Thyroid gland diseases":1,
"Intraparotid node metastasis":1,
"Parotid cancer":1,
"Parotid squamous cell carcinoma":1,
"Prognosis analysis":1,
"Solitary thyroid nodule":1,
"BRAFV600E":1,
"CDK4/6":1,
"clonal evolution":1,
"copy number variations":1,
"microenvironment":1,
"palbociclib":1,
"ultra-precision therapy":1,
"vemurafenib":1,
"Angiopoietin-like 2":1,
"CK19":1,
"TROP-2":1,
"North India":1,
"lung":1,
"NRAS":1,
"TERT promoter":1,
"THY 3":1,
"follicular thyroid carcinoma":2,
"indeterminate lesions":1,
"skin metastasis":1,
"Adrenal gland":1,
"Adrenal neoplasms":1,
"Laparoscopic surgery":1,
"Laparoscopy":1,
"Uterine cancer":1,
"Epstein–Barr Virus Nuclear Antigens":1,
"Familial Hemophagocytic Lymphohistiocytosis, Lymphoma, Perforin Gene Mutation":1,
"Bethesda":1,
"Children":1,
"IASLC/ATS/ERS guidelines":1,
"nomenclature":1,
"small biopsies":1,
"three-step approach":1,
"Autism spectrum disorder":1,
"isolation":1,
"lung metastases":1,
"pediatric":1,
"radioiodine therapy":1,
"Neoplasm":1,
"CA19-9":1,
"Prognostic factor":1,
"Conjunctival inclusion cyst":1,
"Orbital radioiodine uptake":1,
"Case reports":1,
"Head and neck neoplasms":1,
"Laryngeal neoplasms":1,
"Lipoma":1,
"Cushing’s disease":1,
"adrenocorticotropic hormone":1,
"canine":1,
"neuroendocrine tumor":1,
"hyperparathyroidism-jaw tumor syndrome":1,
"pediatric parathyroid carcinoma":1,
"rickets":1,
"genetic alteration":1,
"Cancer risk":1,
"H19":1,
"Polymorphism":1,
"rs217727":1,
"incidental findings":1,
"parathyroid neoplasm":1,
"radionuclide imaging":1,
"benign thyroidectomy":1,
"cervical thyroid remnant":1,
"Disease attribute":1,
"Lymphoma, non-Hodgkin":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年7月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
